PhD Biostatistics Intern: AI-Driven Stats & Simulation

Alexion Pharmaceuticals, Inc.; Boston (MA); On-site; USD 55,000 - 78,000; Full time

Job summary

Alexion Pharma Spain S.L. seeks a Biostatistics Intern (PhD) to support the Quantitative Sciences group at its Boston-Seaport location.

The intern will work on a short-term project including building a statistical application with AI tools, conducting simulations to examine design characteristics, and presenting findings at a departmental seminar. Applicants must be pursuing a PhD in Biostatistics, Statistics, or Mathematics with an anticipated graduation after August 2027.

Qualifications

• Currently pursuing a PhD in Biostatistics, Statistics, or Mathematics.
• Expected graduation date after August 2027.
• US work authorization required; OPT not supported.
• Basic knowledge of adaptive design in clinical trials.
• Familiarity with statistical simulations and independent statistical research.
• Proficient programming in R and SAS; experience with AI tools.
• Excellent writing, communication, and interpersonal skills.
• Must report on-site to Boston-Seaport, MA 3 days per week.
• Program Dates: June 7 – August 13, 2027.

Responsibilities

• Utilize AI tools to develop a statistical app.
• Conduct a comprehensive simulation study to evaluate design characteristics.
• Present intern work at the departmental seminar and write a final report.

Skills

R programming

SAS programming

AI tools usage

Statistical simulations

Education

PhD in Biostatistics, Statistics, or Mathematics

Tools

R

SAS

Python

Job description

Alexion Pharma Spain S.L. seeks a Biostatistics Intern (PhD) to support the Quantitative Sciences group at its Boston-Seaport location.

The intern will work on a short-term project including building a statistical application with AI tools, conducting simulations to examine design characteristics, and presenting findings at a departmental seminar. Applicants must be pursuing a PhD in Biostatistics, Statistics, or Mathematics with an anticipated graduation after August 2027.